Back
ATAI Life Sciences NV Quote, Financials, Valuation and Earnings
Sponsored
ATAI
Sponsored
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
38
ATAI
ATAI Life Sciences NV
Last Price:
1.09
Seasonality Move:
-7.19%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeATAI Life Sciences NV Price Quote
$1.09
+0.01 (+0.93%)
(Updated: November 5, 2024 at 5:14 AM ET)
ATAI Life Sciences NV Key Stats
Sell
38
ATAI Life Sciences NV (ATAI)
is a Sell
Day range:
$1.08 - $1.13
52-week range:
$1.03 - $2.85
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.08%
Volume:
596.5K
Avg. volume:
661.7K
1-year change:
-17.8%
Market cap:
$182.1M
Revenue:
$314K
EPS:
$-0.39
How Much Does ATAI Life Sciences NV Make?
Data Unavailable
Is ATAI Life Sciences NV Growing As A Company?
-
What Is ATAI Life Sciences NV's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.59% -
What Is ATAI Life Sciences NV's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
ATAI Life Sciences NV Stock Price Performance
-
Did ATAI Life Sciences NV Stock Go Up Last Month?
ATAI Life Sciences NV share price went down by -6.47% last month -
Did ATAI's Share Price Rise Over The Last Year?
ATAI share price fell by -17.8% over the past 1 year
What Is ATAI Life Sciences NV 52-Week High & Low?
-
What Is ATAI Life Sciences NV’s 52-Week High Share Price?
ATAI Life Sciences NV has traded as high as $2.85 over the past 52 weeks -
What Is ATAI Life Sciences NV’s 52-Week Low Share Price?
ATAI Life Sciences NV has traded as low as $1.03 over the past 52 weeks
ATAI Life Sciences NV Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy ATAI Life Sciences NV?
-
How Much Debt Does ATAI Life Sciences NV Have?
Total long term debt quarterly is $18.6M -
How Much Cash Does ATAI Life Sciences NV Have?
Cash and short term investments quarterly total is $88.3M -
What Is ATAI Life Sciences NV’s Book Value Per Share?
Book value per share is 1.00
Is ATAI Life Sciences NV Cash Flow Positive?
-
What Is ATAI Cash Flow From Operations?
Cash flow from operations (TTM) is -$79.2M -
What Is ATAI Life Sciences NV’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$8.1M -
What Is ATAI Life Sciences NV’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$19.5M
ATAI Life Sciences NV Return On Invested Capital
-
Is Management Doing A Good Job?
ATAI return on invested capital is -24.06% -
What Is ATAI Life Sciences NV Return On Assets?
ROA measures how assets are converting to revenues and is -21.67% -
What Is ATAI Return On Equity?
ROE is a measure of profitability and is -25.92%
ATAI Life Sciences NV Earnings Date & Stock Price
-
What Is ATAI Life Sciences NV's Stock Price Today?
A single share of ATAI can be purchased today for 1.09 -
What Is ATAI Life Sciences NV’s Stock Symbol?
ATAI Life Sciences NV trades on the nasdaq under the ticker symbol: ATAI -
When Is ATAI Life Sciences NV’s Next Earnings Date?
The next quarterly earnings date for ATAI Life Sciences NV is scheduled on November 14, 2024 -
When Is ATAI's next ex-dividend date?
ATAI Life Sciences NV's next ex-dividend date is November 5, 2024 -
How To Buy ATAI Life Sciences NV Stock?
You can buy ATAI Life Sciences NV shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ATAI Life Sciences NV Competitors
-
Who Are ATAI Life Sciences NV's Competitors?
Below is a list of companies who compete with ATAI Life Sciences NV or are related in some way:
ATAI Life Sciences NV Dividend Yield
-
What Is ATAI Dividend Yield?
ATAI Life Sciences NV’s dividend yield currently is 0% -
What Is ATAI Life Sciences NV’s Payout Ratio?
ATAI Life Sciences NV’s payout ratio is 0% -
When Did ATAI Life Sciences NV Last Pay A Dividend?
The latest dividend pay date is November 5, 2024 -
What Is ATAI Life Sciences NV’s Dividend Per Share?
ATAI Life Sciences NV pays a dividend of $0.00 per share
ATAI Life Sciences NV Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -129.78% |
Revenue: | 58.72% | 0% |
Analyst Recommendations
Buy Recommendations: | 4 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 9.25 |
Upside from Last Price: | 752.53% |